Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). - Carberry J; Petrie MC; Lee MMY; Stanley B; Brooksbank KJM; Campbell RT; Good R; Jhund PS; Kellman P; Lang NN; Lindsay MM; Mangion K; et al. (European journal of heart failure, 2025)